+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Blood Screening Market by Test Type (Hepatitis B Screening, Hepatitis C Screening, HIV Screening), Technology (Chemiluminescence, Flow Cytometry, Immunoassays), End User, Sample Type, Testing Mode - Global Forecast 2025-2030- Product Image
Blood Screening Market by Test Type (Hepatitis B Screening, Hepatitis C Screening, HIV Screening), Technology (Chemiluminescence, Flow Cytometry, Immunoassays), End User, Sample Type, Testing Mode - Global Forecast 2025-2030- Product Image
Sale

Blood Screening Market by Test Type (Hepatitis B Screening, Hepatitis C Screening, HIV Screening), Technology (Chemiluminescence, Flow Cytometry, Immunoassays), End User, Sample Type, Testing Mode - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 199 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 6083561
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The blood screening market is evolving rapidly, shaped by changing health priorities, regulatory shifts, and technological advancement. For organizations navigating diagnostic, procurement, or strategic planning decisions, understanding these dynamics is key to ensuring operational resilience and effective risk management.

Market Snapshot: Blood Screening Market Growth and Trends

The Blood Screening Market grew from USD 5.31 billion in 2024 to USD 5.79 billion in 2025. It is expected to continue growing at a CAGR of 8.84%, reaching USD 8.83 billion by 2030. This upward trend reflects an increased emphasis on early detection and mitigation of infectious diseases, securing transfusion safety, and strengthening public health initiatives on a global scale. Senior leaders in healthcare, diagnostics, and regulatory agencies are responding to both emerging threats and the demands of quality assurance in interconnected systems.

Scope & Segmentation

  • Test Types: Hepatitis B Screening, Hepatitis C Screening, HIV Screening, Syphilis Screening.
  • Technology Platforms: Chemiluminescence, Flow Cytometry, Immunoassays (including Chemiluminescence Immunoassay, Enzyme Linked Immunosorbent Assay, Radioimmunoassay), Molecular Diagnostics (Isothermal Amplification, Next Generation Sequencing, Polymerase Chain Reaction).
  • End Users: Blood Banks, Clinics, Diagnostic Laboratories, Hospitals.
  • Sample Types: Plasma, Serum, Whole Blood.
  • Testing Modes: Lab Based, Point Of Care.
  • Regional Coverage: Americas (including the United States: California, Texas, New York, Florida, Illinois, Pennsylvania, Ohio; Canada; Mexico; Brazil; Argentina), Europe, Middle East & Africa (United Kingdom, Germany, France, Russia, Italy, Spain, United Arab Emirates, Saudi Arabia, South Africa, Denmark, Netherlands, Qatar, Finland, Sweden, Nigeria, Egypt, Turkey, Israel, Norway, Poland, Switzerland), and Asia-Pacific (China, India, Japan, Australia, South Korea, Indonesia, Thailand, Philippines, Malaysia, Singapore, Vietnam, Taiwan).
  • Key Companies Tracked: F. Hoffmann-La Roche Ltd, Abbott Laboratories, Siemens Healthineers AG, Danaher Corporation, Thermo Fisher Scientific Inc., Grifols, S.A., Bio-Rad Laboratories, Inc., Ortho Clinical Diagnostics, Inc., Hologic, Inc., Terumo BCT, Inc.

Key Takeaways

  • Blood screening is central to mitigating public health risks by supporting early detection protocols and upholding transfusion safety standards.
  • Technological integration—such as the use of molecular diagnostics and automation—improves operational efficiency, detection specificity, and rapid turnaround for clinicians and laboratories.
  • Stakeholder collaboration, including partnerships between manufacturers, healthcare providers, and regulatory agencies, accelerates platform innovation and standardizes screening practices globally.
  • Adopting digital tools, like laboratory information management systems and AI-driven data analysis, streamlines workflows and enhances traceability across decentralized testing environments.
  • Varied end-user requirements, from high-volume blood banks to decentralized clinics, shape demand for flexible screening systems and influence instrument deployment and procurement strategies.

Tariff Impact: Navigating Supply Chain and Cost Pressures

Newly introduced United States tariffs in 2025 increased costs for diagnostic equipment and reagents, prompting supply chain reassessments. Manufacturers have diversified sourcing, built regional manufacturing hubs, and adopted leaner inventory practices to absorb pricing pressure and maintain service continuity. These actions underscore the need for adaptive supply chain management and robust operational planning in blood screening services.

Methodology & Data Sources

This report integrates primary data from interviews with clinical and procurement leaders, combined with secondary sources including regulatory guidelines, industry journals, and company disclosures. Analytical frameworks such as SWOT and PESTLE assessments ensure thorough evaluation, while cross-referencing multiple datasets strengthens validity for evidence-based decision-making.

Why This Report Matters

  • Gain targeted insights into market segmentation, technology trends, and regional growth catalysts enabling strategic investments and procurement decisions.
  • Anticipate regulatory, technological, and supply chain changes impacting diagnostic operations, cost, and risk mitigation strategies.
  • Benchmark against leading market competitors and emerging trends to identify avenues for innovation, operational improvement, and cross-sector collaboration.

Conclusion

The Blood Screening Market is undergoing significant transformation, shaped by technology, regulation, and strategic partnerships. Leaders equipped with these insights can drive performance, enhance resilience, and support public health advancement in a changing landscape.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Integration of AI-driven predictive analytics in blood disease screening workflows to improve detection accuracy
5.2. Expansion of at-home blood screening kits leveraging smartphone connectivity and remote lab integration for personalized health monitoring
5.3. Adoption of multiplex immunoassays for simultaneous detection of multiple blood markers enhancing diagnostic efficiency and throughput
5.4. Rising demand for point-of-care blood screening devices in rural and underserved regions to facilitate early disease detection
5.5. Development of next-generation sequencing panels for comprehensive blood-borne pathogen screening in transfusion services
5.6. Regulatory shifts driving harmonization of blood screening standards across emerging markets to streamline global testing protocols
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Blood Screening Market, by Test Type
8.1. Introduction
8.2. Hepatitis B Screening
8.3. Hepatitis C Screening
8.4. HIV Screening
8.5. Syphilis Screening
9. Blood Screening Market, by Technology
9.1. Introduction
9.2. Chemiluminescence
9.3. Flow Cytometry
9.4. Immunoassays
9.4.1. Chemiluminescence Immunoassay
9.4.2. Enzyme Linked Immunosorbent Assay
9.4.3. Radioimmunoassay
9.5. Molecular Diagnostics
9.5.1. Isothermal Amplification
9.5.2. Next Generation Sequencing
9.5.3. Polymerase Chain Reaction
10. Blood Screening Market, by End User
10.1. Introduction
10.2. Blood Banks
10.3. Clinics
10.4. Diagnostic Laboratories
10.5. Hospitals
11. Blood Screening Market, by Sample Type
11.1. Introduction
11.2. Plasma
11.3. Serum
11.4. Whole Blood
12. Blood Screening Market, by Testing Mode
12.1. Introduction
12.2. Lab Based
12.3. Point Of Care
13. Americas Blood Screening Market
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. Argentina
14. Europe, Middle East & Africa Blood Screening Market
14.1. Introduction
14.2. United Kingdom
14.3. Germany
14.4. France
14.5. Russia
14.6. Italy
14.7. Spain
14.8. United Arab Emirates
14.9. Saudi Arabia
14.10. South Africa
14.11. Denmark
14.12. Netherlands
14.13. Qatar
14.14. Finland
14.15. Sweden
14.16. Nigeria
14.17. Egypt
14.18. Turkey
14.19. Israel
14.20. Norway
14.21. Poland
14.22. Switzerland
15. Asia-Pacific Blood Screening Market
15.1. Introduction
15.2. China
15.3. India
15.4. Japan
15.5. Australia
15.6. South Korea
15.7. Indonesia
15.8. Thailand
15.9. Philippines
15.10. Malaysia
15.11. Singapore
15.12. Vietnam
15.13. Taiwan
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. F. Hoffmann-La Roche Ltd
16.3.2. Abbott Laboratories
16.3.3. Siemens Healthineers AG
16.3.4. Danaher Corporation
16.3.5. Thermo Fisher Scientific Inc.
16.3.6. Grifols, S.A.
16.3.7. Bio-Rad Laboratories, Inc.
16.3.8. Ortho Clinical Diagnostics, Inc.
16.3.9. Hologic, Inc.
16.3.10. Terumo BCT, Inc.
17. ResearchAI
18. ResearchStatistics
19. ResearchContacts
20. ResearchArticles
21. Appendix
List of Figures
FIGURE 1. BLOOD SCREENING MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL BLOOD SCREENING MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL BLOOD SCREENING MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL BLOOD SCREENING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL BLOOD SCREENING MARKET SIZE, BY TEST TYPE, 2024 VS 2030 (%)
FIGURE 6. GLOBAL BLOOD SCREENING MARKET SIZE, BY TEST TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL BLOOD SCREENING MARKET SIZE, BY TECHNOLOGY, 2024 VS 2030 (%)
FIGURE 8. GLOBAL BLOOD SCREENING MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL BLOOD SCREENING MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 10. GLOBAL BLOOD SCREENING MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL BLOOD SCREENING MARKET SIZE, BY SAMPLE TYPE, 2024 VS 2030 (%)
FIGURE 12. GLOBAL BLOOD SCREENING MARKET SIZE, BY SAMPLE TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL BLOOD SCREENING MARKET SIZE, BY TESTING MODE, 2024 VS 2030 (%)
FIGURE 14. GLOBAL BLOOD SCREENING MARKET SIZE, BY TESTING MODE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS BLOOD SCREENING MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 16. AMERICAS BLOOD SCREENING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES BLOOD SCREENING MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 18. UNITED STATES BLOOD SCREENING MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA BLOOD SCREENING MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA BLOOD SCREENING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC BLOOD SCREENING MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC BLOOD SCREENING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. BLOOD SCREENING MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 24. BLOOD SCREENING MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 25. BLOOD SCREENING MARKET: RESEARCHAI
FIGURE 26. BLOOD SCREENING MARKET: RESEARCHSTATISTICS
FIGURE 27. BLOOD SCREENING MARKET: RESEARCHCONTACTS
FIGURE 28. BLOOD SCREENING MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. BLOOD SCREENING MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL BLOOD SCREENING MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL BLOOD SCREENING MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL BLOOD SCREENING MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL BLOOD SCREENING MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL BLOOD SCREENING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL BLOOD SCREENING MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL BLOOD SCREENING MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL BLOOD SCREENING MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL BLOOD SCREENING MARKET SIZE, BY HEPATITIS B SCREENING, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL BLOOD SCREENING MARKET SIZE, BY HEPATITIS B SCREENING, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL BLOOD SCREENING MARKET SIZE, BY HEPATITIS C SCREENING, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL BLOOD SCREENING MARKET SIZE, BY HEPATITIS C SCREENING, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL BLOOD SCREENING MARKET SIZE, BY HIV SCREENING, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL BLOOD SCREENING MARKET SIZE, BY HIV SCREENING, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL BLOOD SCREENING MARKET SIZE, BY SYPHILIS SCREENING, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL BLOOD SCREENING MARKET SIZE, BY SYPHILIS SCREENING, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL BLOOD SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL BLOOD SCREENING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL BLOOD SCREENING MARKET SIZE, BY CHEMILUMINESCENCE, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL BLOOD SCREENING MARKET SIZE, BY CHEMILUMINESCENCE, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL BLOOD SCREENING MARKET SIZE, BY FLOW CYTOMETRY, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL BLOOD SCREENING MARKET SIZE, BY FLOW CYTOMETRY, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL BLOOD SCREENING MARKET SIZE, BY IMMUNOASSAYS, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL BLOOD SCREENING MARKET SIZE, BY IMMUNOASSAYS, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL BLOOD SCREENING MARKET SIZE, BY CHEMILUMINESCENCE IMMUNOASSAY, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL BLOOD SCREENING MARKET SIZE, BY CHEMILUMINESCENCE IMMUNOASSAY, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL BLOOD SCREENING MARKET SIZE, BY ENZYME LINKED IMMUNOSORBENT ASSAY, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL BLOOD SCREENING MARKET SIZE, BY ENZYME LINKED IMMUNOSORBENT ASSAY, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL BLOOD SCREENING MARKET SIZE, BY RADIOIMMUNOASSAY, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL BLOOD SCREENING MARKET SIZE, BY RADIOIMMUNOASSAY, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL BLOOD SCREENING MARKET SIZE, BY IMMUNOASSAYS, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL BLOOD SCREENING MARKET SIZE, BY IMMUNOASSAYS, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL BLOOD SCREENING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL BLOOD SCREENING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL BLOOD SCREENING MARKET SIZE, BY ISOTHERMAL AMPLIFICATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL BLOOD SCREENING MARKET SIZE, BY ISOTHERMAL AMPLIFICATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL BLOOD SCREENING MARKET SIZE, BY NEXT GENERATION SEQUENCING, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL BLOOD SCREENING MARKET SIZE, BY NEXT GENERATION SEQUENCING, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL BLOOD SCREENING MARKET SIZE, BY POLYMERASE CHAIN REACTION, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL BLOOD SCREENING MARKET SIZE, BY POLYMERASE CHAIN REACTION, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL BLOOD SCREENING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL BLOOD SCREENING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL BLOOD SCREENING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL BLOOD SCREENING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL BLOOD SCREENING MARKET SIZE, BY BLOOD BANKS, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL BLOOD SCREENING MARKET SIZE, BY BLOOD BANKS, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL BLOOD SCREENING MARKET SIZE, BY CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL BLOOD SCREENING MARKET SIZE, BY CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL BLOOD SCREENING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL BLOOD SCREENING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL BLOOD SCREENING MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL BLOOD SCREENING MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL BLOOD SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL BLOOD SCREENING MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL BLOOD SCREENING MARKET SIZE, BY PLASMA, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL BLOOD SCREENING MARKET SIZE, BY PLASMA, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL BLOOD SCREENING MARKET SIZE, BY SERUM, BY REGION, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL BLOOD SCREENING MARKET SIZE, BY SERUM, BY REGION, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL BLOOD SCREENING MARKET SIZE, BY WHOLE BLOOD, BY REGION, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL BLOOD SCREENING MARKET SIZE, BY WHOLE BLOOD, BY REGION, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL BLOOD SCREENING MARKET SIZE, BY TESTING MODE, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL BLOOD SCREENING MARKET SIZE, BY TESTING MODE, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL BLOOD SCREENING MARKET SIZE, BY LAB BASED, BY REGION, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL BLOOD SCREENING MARKET SIZE, BY LAB BASED, BY REGION, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL BLOOD SCREENING MARKET SIZE, BY POINT OF CARE, BY REGION, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL BLOOD SCREENING MARKET SIZE, BY POINT OF CARE, BY REGION, 2025-2030 (USD MILLION)
TABLE 69. AMERICAS BLOOD SCREENING MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 70. AMERICAS BLOOD SCREENING MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 71. AMERICAS BLOOD SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 72. AMERICAS BLOOD SCREENING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 73. AMERICAS BLOOD SCREENING MARKET SIZE, BY IMMUNOASSAYS, 2018-2024 (USD MILLION)
TABLE 74. AMERICAS BLOOD SCREENING MARKET SIZE, BY IMMUNOASSAYS, 2025-2030 (USD MILLION)
TABLE 75. AMERICAS BLOOD SCREENING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 76. AMERICAS BLOOD SCREENING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 77. AMERICAS BLOOD SCREENING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 78. AMERICAS BLOOD SCREENING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 79. AMERICAS BLOOD SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 80. AMERICAS BLOOD SCREENING MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 81. AMERICAS BLOOD SCREENING MARKET SIZE, BY TESTING MODE, 2018-2024 (USD MILLION)
TABLE 82. AMERICAS BLOOD SCREENING MARKET SIZE, BY TESTING MODE, 2025-2030 (USD MILLION)
TABLE 83. AMERICAS BLOOD SCREENING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 84. AMERICAS BLOOD SCREENING MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 85. UNITED STATES BLOOD SCREENING MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 86. UNITED STATES BLOOD SCREENING MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 87. UNITED STATES BLOOD SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 88. UNITED STATES BLOOD SCREENING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 89. UNITED STATES BLOOD SCREENING MARKET SIZE, BY IMMUNOASSAYS, 2018-2024 (USD MILLION)
TABLE 90. UNITED STATES BLOOD SCREENING MARKET SIZE, BY IMMUNOASSAYS, 2025-2030 (USD MILLION)
TABLE 91. UNITED STATES BLOOD SCREENING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 92. UNITED STATES BLOOD SCREENING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 93. UNITED STATES BLOOD SCREENING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 94. UNITED STATES BLOOD SCREENING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 95. UNITED STATES BLOOD SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 96. UNITED STATES BLOOD SCREENING MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 97. UNITED STATES BLOOD SCREENING MARKET SIZE, BY TESTING MODE, 2018-2024 (USD MILLION)
TABLE 98. UNITED STATES BLOOD SCREENING MARKET SIZE, BY TESTING MODE, 2025-2030 (USD MILLION)
TABLE 99. UNITED STATES BLOOD SCREENING MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 100. UNITED STATES BLOOD SCREENING MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 101. CANADA BLOOD SCREENING MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 102. CANADA BLOOD SCREENING MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 103. CANADA BLOOD SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 104. CANADA BLOOD SCREENING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 105. CANADA BLOOD SCREENING MARKET SIZE, BY IMMUNOASSAYS, 2018-2024 (USD MILLION)
TABLE 106. CANADA BLOOD SCREENING MARKET SIZE, BY IMMUNOASSAYS, 2025-2030 (USD MILLION)
TABLE 107. CANADA BLOOD SCREENING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 108. CANADA BLOOD SCREENING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 109. CANADA BLOOD SCREENING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 110. CANADA BLOOD SCREENING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 111. CANADA BLOOD SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 112. CANADA BLOOD SCREENING MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 113. CANADA BLOOD SCREENING MARKET SIZE, BY TESTING MODE, 2018-2024 (USD MILLION)
TABLE 114. CANADA BLOOD SCREENING MARKET SIZE, BY TESTING MODE, 2025-2030 (USD MILLION)
TABLE 115. MEXICO BLOOD SCREENING MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 116. MEXICO BLOOD SCREENING MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 117. MEXICO BLOOD SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 118. MEXICO BLOOD SCREENING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 119. MEXICO BLOOD SCREENING MARKET SIZE, BY IMMUNOASSAYS, 2018-2024 (USD MILLION)
TABLE 120. MEXICO BLOOD SCREENING MARKET SIZE, BY IMMUNOASSAYS, 2025-2030 (USD MILLION)
TABLE 121. MEXICO BLOOD SCREENING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 122. MEXICO BLOOD SCREENING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 123. MEXICO BLOOD SCREENING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 124. MEXICO BLOOD SCREENING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 125. MEXICO BLOOD SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 126. MEXICO BLOOD SCREENING MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 127. MEXICO BLOOD SCREENING MARKET SIZE, BY TESTING MODE, 2018-2024 (USD MILLION)
TABLE 128. MEXICO BLOOD SCREENING MARKET SIZE, BY TESTING MODE, 2025-2030 (USD MILLION)
TABLE 129. BRAZIL BLOOD SCREENING MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 130. BRAZIL BLOOD SCREENING MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 131. BRAZIL BLOOD SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 132. BRAZIL BLOOD SCREENING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 133. BRAZIL BLOOD SCREENING MARKET SIZE, BY IMMUNOASSAYS, 2018-2024 (USD MILLION)
TABLE 134. BRAZIL BLOOD SCREENING MARKET SIZE, BY IMMUNOASSAYS, 2025-2030 (USD MILLION)
TABLE 135. BRAZIL BLOOD SCREENING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 136. BRAZIL BLOOD SCREENING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 137. BRAZIL BLOOD SCREENING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 138. BRAZIL BLOOD SCREENING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 139. BRAZIL BLOOD SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 140. BRAZIL BLOOD SCREENING MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 141. BRAZIL BLOOD SCREENING MARKET SIZE, BY TESTING MODE, 2018-2024 (USD MILLION)
TABLE 142. BRAZIL BLOOD SCREENING MARKET SIZE, BY TESTING MODE, 2025-2030 (USD MILLION)
TABLE 143. ARGENTINA BLOOD SCREENING MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 144. ARGENTINA BLOOD SCREENING MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 145. ARGENTINA BLOOD SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 146. ARGENTINA BLOOD SCREENING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 147. ARGENTINA BLOOD SCREENING MARKET SIZE, BY IMMUNOASSAYS, 2018-2024 (USD MILLION)
TABLE 148. ARGENTINA BLOOD SCREENING MARKET SIZE, BY IMMUNOASSAYS, 2025-2030 (USD MILLION)
TABLE 149. ARGENTINA BLOOD SCREENING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 150. ARGENTINA BLOOD SCREENING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 151. ARGENTINA BLOOD SCREENING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 152. ARGENTINA BLOOD SCREENING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 153. ARGENTINA BLOOD SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 154. ARGENTINA BLOOD SCREENING MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 155. ARGENTINA BLOOD SCREENING MARKET SIZE, BY TESTING MODE, 2018-2024 (USD MILLION)
TABLE 156. ARGENTINA BLOOD SCREENING MARKET SIZE, BY TESTING MODE, 2025-2030 (USD MILLION)
TABLE 157. EUROPE, MIDDLE EAST & AFRICA BLOOD SCREENING MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 158. EUROPE, MIDDLE EAST & AFRICA BLOOD SCREENING MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 159. EUROPE, MIDDLE EAST & AFRICA BLOOD SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 160. EUROPE, MIDDLE EAST & AFRICA BLOOD SCREENING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 161. EUROPE, MIDDLE EAST & AFRICA BLOOD SCREENING MARKET SIZE, BY IMMUNOASSAYS, 2018-2024 (USD MILLION)
TABLE 162. EUROPE, MIDDLE EAST & AFRICA BLOOD SCREENING MARKET SIZE, BY IMMUNOASSAYS, 2025-2030 (USD MILLION)
TABLE 163. EUROPE, MIDDLE EAST & AFRICA BLOOD SCREENING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 164. EUROPE, MIDDLE EAST & AFRICA BLOOD SCREENING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 165. EUROPE, MIDDLE EAST & AFRICA BLOOD SCREENING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 166. EUROPE, MIDDLE EAST & AFRICA BLOOD SCREENING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 167. EUROPE, MIDDLE EAST & AFRICA BLOOD SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 168. EUROPE, MIDDLE EAST & AFRICA BLOOD SCREENING MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 169. EUROPE, MIDDLE EAST & AFRICA BLOOD SCREENING MARKET SIZE, BY TESTING MODE, 2018-2024 (USD MILLION)
TABLE 170. EUROPE, MIDDLE EAST & AFRICA BLOOD SCREENING MARKET SIZE, BY TESTING MODE, 2025-2030 (USD MILLION)
TABLE 171. EUROPE, MIDDLE EAST & AFRICA BLOOD SCREENING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 172. EUROPE, MIDDLE EAST & AFRICA BLOOD SCREENING MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 173. UNITED KINGDOM BLOOD SCREENING MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 174. UNITED KINGDOM BLOOD SCREENING MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 175. UNITED KINGDOM BLOOD SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 176. UNITED KINGDOM BLOOD SCREENING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 177. UNITED KINGDOM BLOOD SCREENING MARKET SIZE, BY IMMUNOASSAYS, 2018-2024 (USD MILLION)
TABLE 178. UNITED KINGDOM BLOOD SCREENING MARKET SIZE, BY IMMUNOASSAYS, 2025-2030 (USD MILLION)
TABLE 179. UNITED KINGDOM BLOOD SCREENING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 180. UNITED KINGDOM BLOOD SCREENING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 181. UNITED KINGDOM BLOOD SCREENING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 182. UNITED KINGDOM BLOOD SCREENING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 183. UNITED KINGDOM BLOOD SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 184. UNITED KINGDOM BLOOD SCREENING MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 185. UNITED KINGDOM BLOOD SCREENING MARKET SIZE, BY TESTING MODE, 2018-2024 (USD MILLION)
TABLE 186. UNITED KINGDOM BLOOD SCREENING MARKET SIZE, BY TESTING MODE, 2025-2030 (USD MILLION)
TABLE 187. GERMANY BLOOD SCREENING MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 188. GERMANY BLOOD SCREENING MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 189. GERMANY BLOOD SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 190. GERMANY BLOOD SCREENING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 191. GERMANY BLOOD SCREENING MARKET SIZE, BY IMMUNOASSAYS, 2018-2024 (USD MILLION)
TABLE 192. GERMANY BLOOD SCREENING MARKET SIZE, BY IMMUNOASSAYS, 2025-2030 (USD MILLION)
TABLE 193. GERMANY BLOOD SCREENING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 194. GERMANY BLOOD SCREENING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 195. GERMANY BLOOD SCREENING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 196. GERMANY BLOOD SCREENING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 197. GERMANY BLOOD SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 198. GERMANY BLOOD SCREENING MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 199. GERMANY BLOOD SCREENING MARKET SIZE, BY TESTING MODE, 2018-2024 (USD MILLION)
TABLE 200. GERMANY BLOOD SCREENING MARKET SIZE, BY TESTING MODE, 2025-2030 (USD MILLION)
TABLE 201. FRANCE BLOOD SCREENING MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 202. FRANCE BLOOD SCREENING MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 203. FRANCE BLOOD SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 204. FRANCE BLOOD SCREENING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 205. FRANCE BLOOD SCREENING MARKET SIZE, BY IMMUNOASSAYS, 2018-2024 (USD MILLION)
TABLE 206. FRANCE BLOOD SCREENING MARKET SIZE, BY IMMUNOASSAYS, 2025-2030 (USD MILLION)
TABLE 207. FRANCE BLOOD SCREENING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 208. FRANCE BLOOD SCREENING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 209. FRANCE BLOOD SCREENING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 210. FRANCE BLOOD SCREENING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 211. FRANCE BLOOD SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 212. FRANCE BLOOD SCREENING MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 213. FRANCE BLOOD SCREENING MARKET SIZE, BY TESTING MODE, 2018-2024 (USD MILLION)
TABLE 214. FRANCE BLOOD SCREENING MARKET SIZE, BY TESTING MODE, 2025-2030 (USD MILLION)
TABLE 215. RUSSIA BLOOD SCREENING MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 216. RUSSIA BLOOD SCREENING MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 217. RUSSIA BLOOD SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 218. RUSSIA BLOOD SCREENING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 219. RUSSIA BLOOD SCREENING MARKET SIZE, BY IMMUNOASSAYS, 2018-2024 (USD MILLION)
TABLE 220. RUSSIA BLOOD SCREENING MARKET SIZE, BY IMMUNOASSAYS, 2025-2030 (USD MILLION)
TABLE 221. RUSSIA BLOOD SCREENING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 222. RUSSIA BLOOD SCREENING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 223. RUSSIA BLOOD SCREENING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 224. RUSSIA BLOOD SCREENING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 225. RUSSIA BLOOD SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 226. RUSSIA BLOOD SCREENING MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 227. RUSSIA BLOOD SCREENING MARKET SIZE, BY TESTING MODE, 2018-2024 (USD MILLION)
TABLE 228. RUSSIA BLOOD SCREENING MARKET SIZE, BY TESTING MODE, 2025-2030 (USD MILLION)
TABLE 229. ITALY BLOOD SCREENING MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 230. ITALY BLOOD SCREENING MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 231. ITALY BLOOD SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 232. ITALY BLOOD SCREENING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 233. ITALY BLOOD SCREENING MARKET SIZE, BY IMMUNOASSAYS, 2018-2024 (USD MILLION)
TABLE 234. ITALY BLOOD SCREENING MARKET SIZE, BY IMMUNOASSAYS, 2025-2030 (USD MILLION)
TABLE 235. ITALY BLOOD SCREENING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 236. ITALY BLOOD SCREENING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 237. ITALY BLOOD SCREENING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 238. ITALY BLOOD SCREENING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 239. ITALY BLOOD SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 240. ITALY BLOOD SCREENING MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 241. ITALY BLOOD SCREENING MARKET SIZE, BY TESTING MODE, 2018-2024 (USD MILLION)
TABLE 242. ITALY BLOOD SCREENING MARKET SIZE, BY TESTING MODE, 2025-2030 (USD MILLION)
TABLE 243. SPAIN BLOOD SCREENING MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 244. SPAIN BLOOD SCREENING MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 245. SPAIN BLOOD SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 246. SPAIN BLOOD SCREENING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 247. SPAIN BLOOD SCREENING MARKET SIZE, BY IMMUNOASSAYS, 2018-2024 (USD MILLION)
TABLE 248. SPAIN BLOOD SCREENING MARKET SIZE, BY IMMUNOASSAYS, 2025-2030 (USD MILLION)
TABLE 249. SPAIN BLOOD SCREENING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 250. SPAIN BLOOD SCREENING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 251. SPAIN BLOOD SCREENING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 252. SPAIN BLOOD SCREENING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 253. SPAIN BLOOD SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 254. SPAIN BLOOD SCREENING MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 255. SPAIN BLOOD SCREENING MARKET SIZE, BY TESTING MODE, 2018-2024 (USD MILLION)
TABLE 256. SPAIN BLOOD SCREENING MARKET SIZE, BY TESTING MODE, 2025-2030 (USD MILLION)
TABLE 257. UNITED ARAB EMIRATES BLOOD SCREENING MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 258. UNITED ARAB EMIRATES BLOOD SCREENING MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 259. UNITED ARAB EMIRATES BLOOD SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 260. UNITED ARAB EMIRATES BLOOD SCREENING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 261. UNITED ARAB EMIRATES BLOOD SCREENING MARKET SIZE, BY IMMUNOASSAYS, 2018-2024 (USD MILLION)
TABLE 262. UNITED ARAB EMIRATES BLOOD SCREENING MARKET SIZE, BY IMMUNOASSAYS, 2025-2030 (USD MILLION)
TABLE 263. UNITED ARAB EMIRATES BLOOD SCREENING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 264. UNITED ARAB EMIRATES BLOOD SCREENING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 265. UNITED ARAB EMIRATES BLOOD SCREENING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 266. UNITED ARAB EMIRATES BLOOD SCREENING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 267. UNITED ARAB EMIRATES BLOOD SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 268. UNITED ARAB EMIRATES BLOOD SCREENING MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 269. UNITED ARAB EMIRATES BLOOD SCREENING MARKET SIZE, BY TESTING MODE, 2018-2024 (USD MILLION)
TABLE 270. UNITED ARAB EMIRATES BLOOD SCREENING MARKET SIZE, BY TESTING MODE, 2025-2030 (USD MILLION)
TABLE 271. SAUDI ARABIA BLOOD SCREENING MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 272. SAUDI ARABIA BLOOD SCREENING MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 273. SAUDI ARABIA BLOOD SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 274. SAUDI ARABIA BLOOD SCREENING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 275. SAUDI ARABIA BLOOD SCREENING MARKET SIZE, BY IMMUNOASSAYS, 2018-2024 (USD MILLION)
TABLE 276. SAUDI ARABIA BLOOD SCREENING MARKET SIZE, BY IMMUNOASSAYS, 2025-2030 (USD MILLION)
TABLE 277. SAUDI ARABIA BLOOD SCREENING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 278. SAUDI ARABIA BLOOD SCREENING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 279. SAUDI ARABIA BLOOD SCREENING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 280. SAUDI ARABIA BLOOD SCREENING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 281. SAUDI ARABIA BLOOD SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 282. SAUDI ARABIA BLOOD SCREENING MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 283. SAUDI ARABIA BLOOD SCREENING MARKET SIZE, BY TESTING MODE, 2018-2024 (USD MILLION)
TABLE 284. SAUDI ARABIA BLOOD SCREENING MARKET SIZE, BY TESTING MODE, 2025-2030 (USD MILLION)
TABLE 285. SOUTH AFRICA BLOOD SCREENING MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 286. SOUTH AFRICA BLOOD SCREENING MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 287. SOUTH AFRICA BLOOD SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 288. SOUTH AFRICA BLOOD SCREENING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 289. SOUTH AFRICA BLOOD SCREENING MARKET SIZE, BY IMMUNOASSAYS, 2018-2024 (USD MILLION)
TABLE 290. SOUTH AFRICA BLOOD SCREENING MARKET SIZE, BY IMMUNOASSAYS, 2025-2030 (USD MILLION)
TABLE 291. SOUTH AFRICA BLOOD SCREENING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 292. SOUTH AFRICA BLOOD SCREENING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 293. SOUTH AFRICA BLOOD SCREENING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 294. SOUTH AFRICA BLOOD SCREENING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 295. SOUTH AFRICA BLOOD SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 296. SOUTH AFRICA BLOOD SCREENING MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 297. SOUTH AFRICA BLOOD SCREENING MARKET SIZE, BY TESTING MODE, 2018-2024 (USD MILLION)
TABLE 298. SOUTH AFRICA BLOOD SCREENING MARKET SIZE, BY TESTING MODE, 2025-2030 (USD MILLION)
TABLE 299. DENMARK BLOOD SCREENING MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 300. DENMARK BLOOD SCREENING MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 301. DENMARK BLOOD SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 302. DENMARK BLOOD SCREENING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 303. DENMARK BLOOD SCREENING MARKET SIZE, BY IMMUNOASSAYS, 2018-2024 (USD MILLION)
TABLE 304. DENMARK BLOOD SCREENING MARKET SIZE, BY IMMUNOASSAYS, 2025-2030 (USD MILLION)
TABLE 305. DENMARK BLOOD SCREENING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 306. DENMARK BLOOD SCREENING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 307. DENMARK BLOOD SCREENING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 308. DENMARK BLOOD SCREENING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 309. DENMARK BLOOD SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 310. DENMARK BLOOD SCREENING MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 311. DENMARK BLOOD SCREENING MARKET SIZE, BY TESTING MODE, 2018-2024 (USD MILLION)
TABLE 312. DENMARK BLOOD SCREENING MARKET SIZE, BY TESTING MODE, 2025-2030 (USD MILLION)
TABLE 313. NETHERLANDS BLOOD SCREENING MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 314. NETHERLANDS BLOOD SCREENING MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 315. NETHERLANDS BLOOD SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 316. NETHERLANDS BLOOD SCREENING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 317. NETHERLANDS BLOOD SCREENING MARKET SIZE, BY IMMUNOASSAYS, 2018-2024 (USD MILLION)
TABLE 318. NETHERLANDS BLOOD SCREENING MARKET SIZE, BY IMMUNOASSAYS, 2025-2030 (USD MILLION)
TABLE 319. NETHERLANDS BLOOD SCREENING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 320. NETHERLANDS BLOOD SCREENING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 321. NETHERLANDS BLOOD SCREENING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 322. NETHERLANDS BLOOD SCREENING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 323. NETHERLANDS BLOOD SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 324. NETHERLANDS BLOOD SCREENING MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 325. NETHERLANDS BLOOD SCREENING MARKET SIZE, BY TESTING MODE, 2018-2024 (USD MILLION)
TABLE 326. NETHERLANDS BLOOD SCREENING MARKET SIZE, BY TESTING MODE, 2025-2030 (USD MILLION)
TABLE 327. QATAR BLOOD SCREENING MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 328. QATAR BLOOD SCREENING MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 329. QATAR BLOOD SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 330. QATAR BLOOD SCREENING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 331. QATAR BLOOD SCREENING MARKET SIZE, BY IMMUNOASSAYS, 2018-2024 (USD MILLION)
TABLE 332. QATAR BLOOD SCREENING MARKET SIZE, BY IMMUNOASSAYS, 2025-2030 (USD MILLION)
TABLE 333. QATAR BLOOD SCREENING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 334. QATAR BLOOD SCREENING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 335. QATAR BLOOD SCREENING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 336. QATAR BLOOD SCREENING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 337. QATAR BLOOD SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 338. QATAR BLOOD SCREENING MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 339. QATAR BLOOD SCREENING MARKET SIZE, BY TESTING MODE, 2018-2024 (USD MILLION)
TABLE 340. QATAR BLOOD SCREENING MARKET SIZE, BY TESTING MODE, 2025-2030 (USD MILLION)
TABLE 341. FINLAND BLOOD SCREENING MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 342. FINLAND BLOOD SCREENING MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 343. FINLAND BLOOD SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 344. FINLAND BLOOD SCREENING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 345. FINLAND BLOOD SCREENING MARKET SIZE, BY IMMUNOASSAYS, 2018-2024 (USD MILLION)
TABLE 346. FINLAND BLOOD SCREENING MARKET SIZE, BY IMMUNOASSAYS, 2025-2030 (USD MILLION)
TABLE 347. FINLAND BLOOD SCREENING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 348. FINLAND BLOOD SCREENING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 349. FINLAND BLOOD SCREENING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 350. FINLAND BLOOD SCREENING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 351. FINLAND BLOOD SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 352. FINLAND BLOOD SCREENING MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 353. FINLAND BLOOD SCREENING MARKET SIZE, BY TESTING MODE, 2018-2024 (USD MILLION)
TABLE 354. FINLAND BLOOD SCREENING MARKET SIZE, BY TESTING MODE, 2025-2030 (USD MILLION)
TABLE 355. SWEDEN BLOOD SCREENING MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 356. SWEDEN BLOOD

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Blood Screening market report include:
  • F. Hoffmann-La Roche Ltd
  • Abbott Laboratories
  • Siemens Healthineers AG
  • Danaher Corporation
  • Thermo Fisher Scientific Inc.
  • Grifols, S.A.
  • Bio-Rad Laboratories, Inc.
  • Ortho Clinical Diagnostics, Inc.
  • Hologic, Inc.
  • Terumo BCT, Inc.

Table Information

Report AttributeDetails
No. of Pages199
PublishedAugust 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 5.79 Billion
Forecasted Market Value ( USD ) by 2030 $ 8.83 Billion
Compound Annual Growth Rate8.8%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Blood Screening Market Size, Share & Trends Analysis Report by Technology (Nucleic Acid Amplification Test, ELISA, Western Blotting), Product (Reagent, Instrument), Region, and Segment Forecasts, 2025-2030 - Product Image

Blood Screening Market Size, Share & Trends Analysis Report by Technology (Nucleic Acid Amplification Test, ELISA, Western Blotting), Product (Reagent, Instrument), Region, and Segment Forecasts, 2025-2030

  • Report
  • 90 Pages
  • Global
From
Blood Screening Market - Global Industry Size, Share, Trends, Opportunity and Forecast, 2019-2029F - Product Image

Blood Screening Market - Global Industry Size, Share, Trends, Opportunity and Forecast, 2019-2029F

  • Report
  • 187 Pages
  • Global
From
Blood Screening - Global Strategic Business Report - Product Image

Blood Screening - Global Strategic Business Report

  • Report
  • 158 Pages
  • Global
From
Blood Screening Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2032 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa) - Product Image

Blood Screening Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2032 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

  • Report
  • 210 Pages
  • Global
From
Blood Screening Market Report 2025 - Product Image

Blood Screening Market Report 2025

  • Report
  • 200 Pages
  • Global
From

About the Blood Screening Market

The Blood Screening market within the context of In Vitro Diagnostics is a rapidly growing sector of the healthcare industry. It involves the use of laboratory tests to detect and diagnose diseases and other medical conditions. These tests are used to detect a wide range of conditions, including infections, genetic disorders, and cancer. Blood screening tests are used to detect the presence of antibodies, antigens, and other markers that can indicate the presence of a disease or condition. Blood screening tests are used in a variety of settings, including hospitals, clinics, and laboratories. They are also used in research and development, as well as in the development of new treatments and therapies. Blood screening tests are used to monitor the health of patients, as well as to detect and diagnose diseases and other medical conditions. Some of the major companies in the Blood Screening market include Abbott Laboratories, Becton Dickinson, Bio-Rad Laboratories, Cepheid, and Roche Diagnostics. These companies provide a wide range of products and services, including diagnostic tests, reagents, and instruments. They also offer a variety of services, such as consulting, training, and support. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.